Results 111 to 120 of about 36,320 (224)

Early parenteral prostacyclin therapy enables near-normal haemodynamics and treatment de-escalation in patients with haemodynamically severe pulmonary arterial hypertension. [PDF]

Eur Respir J
Kuronuma K, Quadery SR, Suetomi T, Goten C, Shimokawahara H, Matsubara H.   +5 more
europepmc   +1 more source

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension. [PDF]

ERJ Open Res
AlEissa E, Kolkman L, Kapasi A, Peng D, Provencher S, Brunner N, Swiston J.   +6 more
europepmc   +1 more source

Synthesis of Protocols for Frostbite Care From the FROST Study Sites. [PDF]

J Burn Care Res
Nygaard RM, Colonna E, Poole A, Faucher LD, Paine RE, Sangji N, Lacey A, Bhavsar D, Colling K, Armour A, Fleming I, Wiktor A, Wibbenmeyer L, FROST multicenter study team.   +13 more
europepmc   +1 more source

In Patients Experiencing Pain and Inflammation, the Use of Non-Steroidal Anti-Inflammatory Drugs Is More Likely a Marker of the Observed Cardiovascular Risk Rather than Its Cause: A Viewpoint. [PDF]

Pharmacy (Basel)
Zingler G, Herdegen T.
europepmc   +1 more source

Parenteral Treprostinil as an Effective Bridge to Lung Transplant in Patients with Severe Pulmonary Hypertension Associated with Interstitial Lung Disease. [PDF]

J Cardiovasc Dev Dis
Hopkins J, Gayen S.
europepmc   +1 more source

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration

Frontiers in Pediatrics, 2023
Jenna M. Faircloth, Neelam D. Bhatt, Corey A. Chartan, Ryan D. Coleman, Natalie Villafranco, Fadel E. Ruiz, Raysa Morales-Demori, Elise Whalen, Erin Ely, Rozmeen Fombin, Nidhy P. Varghese   +10 more
doaj   +1 more source

Beyond Vasodilation: Sotatercept and the Dawn of Disease Modification in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. [PDF]

Int J Rheum Dis
Su ST, Wang CY, Shih PC.
europepmc   +1 more source

Prostacyclin in Lung Cancer [PDF]

Journal of Thoracic Oncology, 2006
Keith, Robert L., Geraci, Mark W.
openaire   +2 more sources

Clinical Practice of Pulmonary Arterial Hypertension (PAH) and Potential Barriers to Intensive Treatment Among PAH-Specialized and Non-PAH-Specialized Centers in Japan. [PDF]

Pulm Circ
Arai Y, Zhang W, Yamauchi S, Tokita S, Akutsu S.   +4 more
europepmc   +1 more source

Transitions From Parenteral Prostacyclin Analogues to Selexipag in Patients With Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Kuebel DJ, Collins AR, Jose A, Guido MR, Elwing JM.   +4 more
europepmc   +1 more source